Advanced Medical Solutions Group plc

LSE:AMS UK Medical Instruments & Supplies
Market Cap
$5.18 Million
GBX42.58 Billion GBX
Market Cap Rank
#42047 Global
#629 in UK
Share Price
GBX196.80
Change (1 day)
+1.44%
52-Week Range
GBX176.60 - GBX237.00
All Time High
GBX352.89
Categories
Companies in UK Medical Instruments & Supplies
About

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats,… Read more

Advanced Medical Solutions Group plc (AMS) - Net Assets

Latest net assets as of June 2025: GBX256.93 Million GBX

Based on the latest financial reports, Advanced Medical Solutions Group plc (AMS) has net assets worth GBX256.93 Million GBX as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX397.44 Million) and total liabilities (GBX140.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX256.93 Million
% of Total Assets 64.65%
Annual Growth Rate 13.76%
5-Year Change 19.44%
10-Year Change 133.0%
Growth Volatility 37.53

Advanced Medical Solutions Group plc - Net Assets Trend (1994–2024)

This chart illustrates how Advanced Medical Solutions Group plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Advanced Medical Solutions Group plc (1994–2024)

The table below shows the annual net assets of Advanced Medical Solutions Group plc from 1994 to 2024.

Year Net Assets Change
2024-12-31 GBX241.52 Million -1.10%
2023-12-31 GBX244.20 Million +3.20%
2022-12-31 GBX236.62 Million +11.26%
2021-12-31 GBX212.68 Million +5.18%
2020-12-31 GBX202.21 Million +5.74%
2019-12-31 GBX191.24 Million +10.72%
2018-12-31 GBX172.72 Million +13.31%
2017-12-31 GBX152.44 Million +21.44%
2016-12-31 GBX125.53 Million +21.10%
2015-12-31 GBX103.66 Million +11.40%
2014-12-31 GBX93.05 Million +8.09%
2013-12-31 GBX86.09 Million +16.81%
2012-12-31 GBX73.70 Million +11.31%
2011-12-31 GBX66.21 Million +138.17%
2010-12-31 GBX27.80 Million +21.66%
2009-12-31 GBX22.85 Million +14.87%
2008-12-31 GBX19.89 Million +26.33%
2007-12-31 GBX15.75 Million +20.67%
2006-12-31 GBX13.05 Million +10.15%
2005-12-31 GBX11.85 Million +2.36%
2004-12-31 GBX11.57 Million -3.58%
2003-12-31 GBX12.00 Million -14.91%
2002-12-31 GBX14.11 Million +17.62%
2001-12-31 GBX11.99 Million -10.85%
2000-12-31 GBX13.45 Million +40.29%
1999-12-31 GBX9.59 Million -34.91%
1998-12-31 GBX14.73 Million +61.99%
1997-12-31 GBX9.10 Million +79.64%
1996-12-31 GBX5.06 Million +116.37%
1995-12-31 GBX2.34 Million -53.61%
1994-12-31 GBX5.04 Million --

Equity Component Analysis

This analysis shows how different components contribute to Advanced Medical Solutions Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 18307000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings GBX180.47 Million 74.95%
Common Stock GBX10.89 Million 4.52%
Other Comprehensive Income GBX17.23 Million 7.16%
Other Components GBX32.18 Million 13.36%
Total Equity GBX240.78 Million 100.00%

Advanced Medical Solutions Group plc Competitors by Market Cap

The table below lists competitors of Advanced Medical Solutions Group plc ranked by their market capitalization.

Company Market Cap
Shandong Senter Electn Co Ltd
SHE:001388
 		$57.68K
Kardan NV
TA:KRNV
 		$57.69K
SILO WELLNESS INC.
F:3K7A
 		$57.71K
Ligand Pharms Inc Cvr
PINK:LGNDZ
 		$57.77K
EASYJET
BE:EJT1
 		$57.66K
Plantx Life Inc.
PINK:PLTXF
 		$57.65K
IPE Universal Inc
PINK:IPEU
 		$57.65K
SALVAT.FERRAGAMO (S9L.SG)
STU:S9L
 		$57.63K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Advanced Medical Solutions Group plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 244,202,000 to 240,777,000, a change of -3,425,000 (-1.4%).
  • Net income of 7,094,000 contributed positively to equity growth.
  • Dividend payments of 5,201,000 reduced retained earnings.
  • New share issuances of 12,000 increased equity.
  • Other comprehensive income decreased equity by 5,445,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX7.09 Million +2.95%
Dividends Paid GBX5.20 Million -2.16%
Share Issuances GBX12.00K +0.0%
Other Comprehensive Income GBX-5.45 Million -2.26%
Other Changes GBX115.00K +0.05%
Total Change GBX- -1.40%

Book Value vs Market Value Analysis

This analysis compares Advanced Medical Solutions Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 178.43x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 859.18x to 178.43x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1994-12-31 GBX0.23 GBX196.80 x
1995-12-31 GBX0.09 GBX196.80 x
1996-12-31 GBX0.15 GBX196.80 x
1997-12-31 GBX0.24 GBX196.80 x
1998-12-31 GBX0.34 GBX196.80 x
1999-12-31 GBX0.14 GBX196.80 x
2000-12-31 GBX0.14 GBX196.80 x
2001-12-31 GBX0.13 GBX196.80 x
2002-12-31 GBX0.11 GBX196.80 x
2003-12-31 GBX0.08 GBX196.80 x
2004-12-31 GBX0.08 GBX196.80 x
2005-12-31 GBX0.08 GBX196.80 x
2006-12-31 GBX0.09 GBX196.80 x
2007-12-31 GBX0.10 GBX196.80 x
2008-12-31 GBX0.13 GBX196.80 x
2009-12-31 GBX0.15 GBX196.80 x
2010-12-31 GBX0.18 GBX196.80 x
2011-12-31 GBX0.41 GBX196.80 x
2012-12-31 GBX0.35 GBX196.80 x
2013-12-31 GBX0.41 GBX196.80 x
2014-12-31 GBX0.44 GBX196.80 x
2015-12-31 GBX0.49 GBX196.80 x
2016-12-31 GBX0.59 GBX196.80 x
2017-12-31 GBX0.71 GBX196.80 x
2018-12-31 GBX0.80 GBX196.80 x
2019-12-31 GBX0.88 GBX196.80 x
2020-12-31 GBX0.93 GBX196.80 x
2021-12-31 GBX0.97 GBX196.80 x
2022-12-31 GBX1.08 GBX196.80 x
2023-12-31 GBX1.11 GBX196.80 x
2024-12-31 GBX1.10 GBX196.80 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Advanced Medical Solutions Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 2.95%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 4.00%
  • • Asset Turnover: 0.46x
  • • Equity Multiplier: 1.62x
  • Recent ROE (2.95%) is above the historical average (-7.47%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1994 -34.42% -5260.61% 0.01x 1.16x GBX-2.24 Million
1995 -115.56% -1445.99% 0.06x 1.41x GBX-2.94 Million
1996 -78.75% -276.11% 0.23x 1.26x GBX-4.49 Million
1997 -61.43% -170.86% 0.23x 1.54x GBX-6.50 Million
1998 -33.41% -91.39% 0.30x 1.21x GBX-6.40 Million
1999 -53.76% -82.88% 0.51x 1.27x GBX-6.12 Million
2000 -19.96% -34.37% 0.49x 1.19x GBX-4.03 Million
2001 -12.26% -19.94% 0.53x 1.17x GBX-2.67 Million
2002 -9.90% -16.69% 0.51x 1.16x GBX-2.81 Million
2003 -17.36% -23.12% 0.62x 1.21x GBX-3.28 Million
2004 -3.60% -3.78% 0.80x 1.20x GBX-1.57 Million
2005 2.33% 2.14% 0.90x 1.21x GBX-908.70K
2006 5.72% 5.22% 0.89x 1.23x GBX-557.90K
2007 14.20% 13.27% 0.88x 1.22x GBX661.40K
2008 16.63% 16.29% 0.83x 1.23x GBX1.32 Million
2009 12.18% 11.56% 0.81x 1.30x GBX499.00K
2010 17.38% 15.16% 0.97x 1.19x GBX2.05 Million
2011 7.32% 14.12% 0.35x 1.50x GBX-1.77 Million
2012 13.15% 18.43% 0.54x 1.32x GBX2.32 Million
2013 13.20% 19.10% 0.61x 1.13x GBX2.76 Million
2014 13.82% 20.42% 0.60x 1.12x GBX3.56 Million
2015 13.62% 20.58% 0.59x 1.12x GBX3.75 Million
2016 12.50% 18.85% 0.57x 1.16x GBX3.14 Million
2017 13.21% 20.78% 0.57x 1.11x GBX4.89 Million
2018 13.11% 22.08% 0.50x 1.19x GBX5.38 Million
2019 9.89% 18.48% 0.45x 1.19x GBX-204.50K
2020 4.25% 9.89% 0.36x 1.18x GBX-11.64 Million
2021 8.22% 16.10% 0.44x 1.17x GBX-3.79 Million
2022 8.62% 16.41% 0.44x 1.19x GBX-3.26 Million
2023 6.51% 12.59% 0.44x 1.18x GBX-8.53 Million
2024 2.95% 4.00% 0.46x 1.62x GBX-16.98 Million

Industry Comparison

This section compares Advanced Medical Solutions Group plc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $22,269,333
  • Average return on equity (ROE) among peers: 5.81%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Advanced Medical Solutions Group plc (AMS) GBX256.93 Million -34.42% 0.55x $57.66K
Cambridge Nutritional Sciences plc (CNSL) $23.38 Million -9.00% 0.26x $579.03
Inspecs Group plc (SPEC) $31.35 Million 15.67% 1.28x $8.66K
Tristel (TSTL) $12.08 Million 10.75% 0.25x $22.16K